ProQR Therapeutics NV (PRQR)

NASDAQ
Currency in USD
Disclaimer
1.500
+0.020
(+1.35%)
Real-time Data
Day's Range
1.490
1.540
52 wk Range
0.722
3.850
Volume
119,791
Prev. Close
1.48
Open
1.54
Day's Range
1.49-1.54
52 wk Range
0.722-3.85
Volume
119,791
Average Volume (3m)
198,847
1-Year Change
94.2%
Shares Outstanding
80,939,812
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
3.950
Upside +163.333%

People Also Watch

9.090
CTIC
0.00%
33.83
MRTX
+4.11%
1.570
ADVM
-2.48%
4.29
CHRS
-4.88%
How do you feel today about PRQR?
Vote to see community's results!
or

ProQR Therapeutics NV Company Profile

ProQR Therapeutics N.V. is a pre-clinical stage biopharmaceutical company based in the Netherlands. The Company is engaged in the discovery and development of ribonucleic Acid (RNA)-based therapeutics for the treatment of severe genetic disorders. It designs its therapeutic candidates to specifically target and repair the defective messenger RNA, or Messenger Ribonucleic Acid (mRNA), that is transcribed from a mutated gene in order to restore the expression and function of normal, or wild-type protein. Its product candidates include QR-010, an RNA-based oligonucleotide for the treatment of cystic fibrosis (CF), QR-110, an oligonucleotide and for the treatment of Leber’s congenital amaurosis (LCA).

Income Statement